Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Conjugated linoleic acid (CLA / Tonalin c9,t11 & t10,c12)

Conjugated Linoleic Acid (CLA / Tonalin) · also known as Conjugated linoleic acid, CLA, Tonalin, Linoleic acid isomers

Conjugated linoleic acid is a mixture of several isomers; c9,t11 is the main one in foods from ruminant animals. Human study results are inconsistent. Some studies suggest the t10,c12 isomer may increase oxidative stress and impair insulin sensitivity, and human evidence for fat loss is insufficient.

Typical dose: Standardized CLA (80% active isomers in a 50:50 ratio) 3000–4000 mg/day, in divided doses with meals
Absorption and forms: It comes as pure oil-soluble free fatty acids or triglycerides. Taking it with a main meal that contains a moderate amount of healthy fat helps digestion and absorption.

Clinical uses and human evidence

Body weight and body fat

Mixed resultsGrade A · Strong evidence
Studies (1)
  1. Asbaghi 2024 · Br J Nutr · Meta-analysis · n=4159 — The effects of conjugated linoleic acid supplementation on anthropometrics and body composition indices in adults: a systematic review and dose-response meta-analysis

Blood sugar and insulin resistance

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Ghodoosi 2023 · Nutr J · Meta-analysis · n=723 — The effects of conjugated linoleic acid supplementation on glycemic control, adipokines, cytokines, malondialdehyde and liver function enzymes in patients at risk of cardiovascular disease: a GRADE-assessed systematic review and dose-response meta-analysis
  2. Liang 2023 · Nutr Rev · Meta-analysis — Effects of conjugated linoleic acid and exercise on body composition and obesity: a systematic review and meta-analysis

Muscle strength and mass

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Asbaghi 2024 · Br J Nutr · Meta-analysis · n=4159 — The effects of conjugated linoleic acid supplementation on anthropometrics and body composition indices in adults: a systematic review and dose-response meta-analysis
  2. Liang 2023 · Nutr Rev · Meta-analysis — Effects of conjugated linoleic acid and exercise on body composition and obesity: a systematic review and meta-analysis

High LDL cholesterol

No benefitGrade A · Strong evidence
Studies (1)
  1. Asbaghi 2022 · Front Nutr · Meta-analysis · n=3262 — The effects of conjugated linoleic acid supplementation on lipid profile in adults: A systematic review and dose-response meta-analysis

High triglycerides

No benefitGrade A · Strong evidence
Studies (1)
  1. Asbaghi 2022 · Front Nutr · Meta-analysis · n=3262 — The effects of conjugated linoleic acid supplementation on lipid profile in adults: A systematic review and dose-response meta-analysis

Mechanisms of action

Acylcarnitine shuttle into mitochondria and β-oxidation

★★★☆☆Mechanism evidence: grade CSecondary target

CLA is not a carnitine-like compound and does not take part directly in the acylcarnitine shuttle. In mice, carnitine palmitoyltransferase activity in muscle or fat tissue rose under some conditions. In a human crossover trial, 3.8 g/day of mixed CLA did not improve measured fat oxidation. The human evidence is inconsistent.

References (2)
  1. Park 1997 · Mouse dietary study: CLA increased total carnitine palmitoyltransferase activity in muscle or fat tissue under some conditions.
  2. Tsao 2015 · Human crossover trial: 3.8 g/day of mixed CLA did not improve measured fat oxidation.

AMPK sensing of cellular energy deficit and metabolic reprogramming

★★★☆☆Mechanism evidence: grade CSecondary target

Inhibition of lipoprotein lipase activity does not, by itself, show that AMPK is activated. AMPK-related effects are seen mainly in mouse and cell models and vary with isomer, tissue and dose. No reliable AMPK-specific marker has yet confirmed the effect in humans taking CLA orally.

References (2)
  1. Zhang 2024 · Mouse study: CLA was associated with activation of the AMPK pathway in fat tissue.
  2. Jiang 2009 · Cell and mouse study: the t10,c12 isomer can modulate AMPK-related signaling.

Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription

★★☆☆☆Mechanism evidence: grade CSecondary target

In animal studies, CLA can downregulate NF-κB-related signaling under some conditions, but the direction of the inflammatory effect differs between isomers. Neither the claim that c9,t11 is a weak PPAR-γ agonist nor a fall in TNF-α is enough on its own to prove that NF-κB is inhibited in humans.

References (2)
  1. Li 2021 · Mouse study: the effect of mixed CLA on TLR4–NF-κB signaling in fat tissue depended on sex.
  2. 2002 · Human RCT: t10,c12 CLA can increase markers of oxidative stress and inflammation.

Safety and drug interactions

People with severe obesity and extreme fatty liver should use it only under a dietitian’s guidance. Some human trials suggest the t10,c12 isomer may increase oxidative stress and impair insulin sensitivity, so people with fatty liver or metabolic disorders should be cautious. The 50:50 mixture common in supplements is not the only effective form, and products with other ratios should not automatically be dismissed as inferior. Choose a product that clearly labels its isomer composition.
Open in the interactive app ›